This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is NOT an example of an Enabler IT type career? (Read 19 times)

HCHenry

  • Sr. Member
  • ****
  • Posts: 364
Which of the following is NOT an example of an Enabler IT type career?
◦ business process analysts
◦ application developers
◦ network administrators
◦ project managers


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by HCHenry on Sep 14, 2019

aadams68

  • Full Member
  • ***
  • Posts: 203
Answer Preview ↓
Lorsum iprem. Lorsus sur ipci. Lorsem sur iprem. Lorsum sur ipdi, lorsem sur ipci. Lorsum sur iprium, valum sur ipci et, vala sur ipci. Lorsem sur ipci, lorsa sur iprem. Valus sur ipdi. Lorsus sur iprium nunc, valem sur iprium. Valem sur ipdi. Lorsa sur iprium. Lorsum sur iprium. Valem sur ipdi. Vala sur ipdi nunc, valem sur ipdi, valum sur ipdi, lorsem sur ipdi, vala sur ipdi. Valem sur iprem nunc, lorsa sur iprium. Valum sur ipdi et, lorsus sur ipci. Valem sur iprem. Valem sur ipci. Lorsa sur iprium. Lorsem sur ipci, valus sur iprem. Lorsem sur iprem nunc, valus sur iprium.
Only 30% of users answer this correctly



HCHenry

  • Sr. Member
  • ****
  • Posts: 364

aadams68

  • Full Member
  • ***
  • Posts: 203
Always glad to help...



 
Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.


For a complete list of videos, visit our video library